Search company, investor...

MediProPharma

medipropharma.com

Stage

Angel | Dead

Total Raised

$870K

Last Raised

$100K

About MediProPharma

MediProPharma is identifying and developing pharmaceuticals for the treatment of CNS (central nervous system) diseases.

Headquarters Location

359 E. Union Mill Dr

Midvale, Utah, 84047,

United States

Missing: MediProPharma's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: MediProPharma's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing MediProPharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

MediProPharma is included in 1 Expert Collection, including Biopharma Tech.

B

Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

MediProPharma Patents

MediProPharma has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/3/2007

10/26/2010

Calcium channel blockers, H1 receptor antagonists, Carboxylate esters, Amines, Ethers

Grant

Application Date

8/3/2007

Grant Date

10/26/2010

Title

Related Topics

Calcium channel blockers, H1 receptor antagonists, Carboxylate esters, Amines, Ethers

Status

Grant

MediProPharma Frequently Asked Questions (FAQ)

  • Where is MediProPharma's headquarters?

    MediProPharma's headquarters is located at 359 E. Union Mill Dr, Midvale.

  • What is MediProPharma's latest funding round?

    MediProPharma's latest funding round is Angel.

  • How much did MediProPharma raise?

    MediProPharma raised a total of $870K.

  • Who are the investors of MediProPharma?

    Investors of MediProPharma include Utah Angels, Kickstart Fund, Sierra Angels, Salt Lake Life Science Angels and Olympus Angels.

  • Who are MediProPharma's competitors?

    Competitors of MediProPharma include Evotec SE, Somaxon Pharmaceuticals, Cardiokine, Alnara Pharmaceuticals, KeyNeurotek Pharmaceuticals and 12 more.

Compare MediProPharma to Competitors

C
Cenes

The company is engaged in developing and commercializing drugs for the hospital-based treatment of central nervous system (CNS) disorders and thrombotic/cardiovascular diseases, indications for which there is a substantial unmet medical need.

Neurelis Logo
Neurelis

Neurelis is a specialty pharmaceutical company that devleops and commercializes product candidates for epilepsy and the broader central nervous system (CNS) market.

L
Labormed Pharma

LaborMed Pharma, aims to offer modern and accessible treatments for cardiovascular diseases, those affecting the central nervous system, the metabolism a.s.o., medicines produced in a state-of-the-art factory in Bucharest.

Neurocure Logo
Neurocure

Neurocure is a specialty pharma company working on psychiatric and central nervous system diseases.

A
Aderis Pharmaceuticals

Aderis Pharmaceuticals, formerly Discovery Therapeutics, develops and commercializes small molecule, receptor-specific therapeutics for the treatment of central nervous system, cardiovascular and renal diseases.

A
Azevan Pharmaceuticals

Azevan Pharmaceuticals is a clinical stage, small molecule drug development company developing novel therapeutics to treat disorders of stress, mood, and behavior. The Company's first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and Major Depression. Vasopressin receptor antagonists represent a novel mechanism of action for addressing these indications.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.